Radiopharm Theranostics (ASX:RAD) Accounts Receivable : A$4.63 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Radiopharm Theranostics's accounts receivables for the quarter that ended in Dec. 2024 was A$4.63 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Radiopharm Theranostics's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 611.06.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Radiopharm Theranostics's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was A$0.00.

Radiopharm Theranostics Accounts Receivable Historical Data

The historical data trend for Radiopharm Theranostics's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Accounts Receivable Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Jun24

Accounts Receivable

0.06

0.11

0.80

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Receivable	Get a 7-Day Free Trial			4.08	0.11	4.41	0.80	4.63

Radiopharm Theranostics Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Radiopharm Theranostics Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Radiopharm Theranostics's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.634	/	1.384	*	91
=	611.06

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Radiopharm Theranostics's accounts receivable are only considered to be worth 75% of book value:

Radiopharm Theranostics's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(36.437	+	0.75 * 4.634	+	0.5 * 0	-	40.449
-	0	-	-1.198)	/	2200.647
=	0.00

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Radiopharm Theranostics Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

RADX:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Radiopharm Theranostics Headlines

No Headlines